OsmoFlo™ Bimodal EVD System
Cerebral edema and elevated intracranial pressure secondary to severe Traumatic Brain Injury (TBI)
Pre-clinical / Early FeasibilityActive
Key Facts
Indication
Cerebral edema and elevated intracranial pressure secondary to severe Traumatic Brain Injury (TBI)
Phase
Pre-clinical / Early Feasibility
Status
Active
Company
About Cerovations
Cerovations is a private, pre-revenue medical device startup targeting the high-need area of severe traumatic brain injury (TBI) management. Its lead innovation, the OsmoFlo™ Bimodal EVD System, has earned FDA Breakthrough Device designation and is supported by an $8M NIH SBIR grant. The company, founded by experienced medtech executives and a clinician-inventor, is preparing for near-term first-in-human clinical trials through the prestigious TRACK-TBI network, aiming to address the significant mortality and poor outcomes associated with treatment-resistant intracranial hypertension.
View full company profile